Pages that link to "Q37659105"
Jump to navigation
Jump to search
The following pages link to Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines (Q37659105):
Displaying 50 items.
- POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance (Q28264404) (← links)
- Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing (Q30234614) (← links)
- The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment (Q30234889) (← links)
- Population-based screening for cancer: hope and hype. (Q30251601) (← links)
- Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study (Q30361978) (← links)
- Lynch syndrome-related small intestinal adenocarcinomas. (Q33591577) (← links)
- Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort (Q33714866) (← links)
- Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol (Q35954744) (← links)
- Sporadic colorectal cancer: Studying ways to an end. (Q36719832) (← links)
- Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target (Q36990060) (← links)
- Reflex test reminders in required cancer synoptic templates decrease order entry error: An analysis of mismatch repair immunohistochemical orders to screen for Lynch syndrome (Q37477005) (← links)
- Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan (Q37670683) (← links)
- Molecular genetics of microsatellite-unstable colorectal cancer for pathologists (Q37680161) (← links)
- Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study. (Q37712344) (← links)
- Lynch syndrome: five unanswered questions (Q38367449) (← links)
- Using Genetics to Identify Hereditary Colorectal Polyposis and Cancer Syndromes in Your Patient (Q38570349) (← links)
- Systematic Review of Hospital Based Cancer Registries (HBCRs): Necessary Tool to Improve Quality of Care in Cancer Patients (Q38607309) (← links)
- A model for patient-direct screening and referral for familial cancer risk. (Q38879087) (← links)
- Diagnosis and Management of Hereditary Adrenal Cancer (Q38881649) (← links)
- Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care (Q38979257) (← links)
- An Individual with Both MUTYH-Associated Polyposis and Lynch Syndrome Identified by Multi-Gene Hereditary Cancer Panel Testing: A Case Report (Q39020597) (← links)
- Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study (Q39668107) (← links)
- Personalised Medicine Approaches to Screening and Prevention (Q40197199) (← links)
- Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer. (Q40386896) (← links)
- Is there a role for prophylactic colectomy in Lynch syndrome patients with inflammatory bowel disease? (Q40494096) (← links)
- High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan (Q40622084) (← links)
- Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts (Q40713486) (← links)
- DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. (Q41024077) (← links)
- Barriers and Facilitating Factors for Implementation of Genetic Services: A Public Health Perspective (Q41243055) (← links)
- A Systematic Review on the Existing Screening Pathways for Lynch Syndrome Identification (Q41684878) (← links)
- Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival (Q41726020) (← links)
- The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from Thailand (Q42143973) (← links)
- Disease Biomarkers in Gastrointestinal Malignancies. (Q42416485) (← links)
- The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in Brazil (Q42699063) (← links)
- Impact of Fecal Hb Levels on Advanced Neoplasia Detection and the Diagnostic Miss Rate For Colorectal Cancer Screening in High-Risk vs. Average-Risk Subjects: a Multi-Center Study (Q47137106) (← links)
- One size may not fit all: the debate of universal tumor testing for Lynch syndrome (Q47397560) (← links)
- Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer (Q47636379) (← links)
- Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial (Q47908752) (← links)
- Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer (Q48653777) (← links)
- Germline mutations in patients with multiple colorectal polyps in China (Q48818506) (← links)
- Reply to the letter to the editor 'Including lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer' by Sciallero et al. (Q50089378) (← links)
- Evolving notions on immune response in colorectal cancer and their implications for biomarker development. (Q50098505) (← links)
- Carcinoma of the lower uterine segment diagnosed with Lynch syndrome based on MSH6 germline mutation: A case report. (Q51280079) (← links)
- Increased lymph node retrieval decreases adjuvant chemotherapy rate for stage II colon cancer. (Q53104911) (← links)
- [Hereditary tumor syndromes in neuropathology]. (Q53312284) (← links)
- Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability. (Q55314343) (← links)
- Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients. (Q55452501) (← links)
- UEG Week 2015 Poster Presentations (Q56934656) (← links)
- Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment (Q57163551) (← links)
- Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts (Q58093325) (← links)